Bartlett & Co’s Tandem Diabetes Care TNDM Stock Holding History

Bartlett & Co’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3	Closed	–	–	1065
2021 Q2	$0	Hold	3	–	–	﹤0.01%	1079
2021 Q1	$0	Hold	3	–	–	﹤0.01%	1172
2020 Q4	$0	Buy	+3	New	+$309	﹤0.01%	1197

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bartlett & Co's TNDM Position: Q3 2021 in Review

Bartlett & Co sold out of Tandem Diabetes Care (TNDM) in Q3 2021, closing a stake of 3 shares.

Bartlett & Co first reported a position in TNDM in Q4 2020 and held it in 3 quarters. The position peaked at $0 in Q2 2021. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

Bartlett & Co reported no remaining Tandem Diabetes Care position as of Q3 2021 after selling out during the quarter.
Bartlett & Co sold 3 Tandem Diabetes Care shares in Q3 2021.
Bartlett & Co first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 3 quarters.
Bartlett & Co's Tandem Diabetes Care position peaked at $0 in Q2 2021.
337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on Bartlett & Co's 13F filing for Q3 2021, filed 15 Oct 2021.